Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily

Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily

Author: Pharma and BioTech News May 7, 2026 Duration: 5:45
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is buzzing with significant shifts driven by scientific advancements, strategic acquisitions, and regulatory changes. A noteworthy transaction is Bayer's $2.4 billion acquisition of Perfuse, aimed at gaining control over an eye disease implant that has shown promising results in phase 2 trials. This acquisition speaks to Bayer’s commitment to expan...

Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: en-us Episodes: 96

Pharma and BioTech Daily
Podcast Episodes